Parnax Lab

Parnax Lab FCF Yield

The Free Cash Flow Yield of Parnax Lab (506128.BO) as of Nov 14, 2026 is 9.61 %. In the previous year, Free Cash Flow Yield was -11.64 % — a change of -182.58% (higher).

FCF Yield

9.61 %

YoY

-182.58%

Last updated:

Free Cash Flow Yield of Parnax Lab is 2025 9.61 % . Free Cash Flow Yield of Parnax Lab was 2024 -11.64 % . It decreases by -182.58% higher compared to the previous year.

The Parnax Lab FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
5.36 INR
Jan 1, 2019
-1.82 INR
Jan 1, 2020
-3.11 INR
Jan 1, 2021
-0.16 INR
Jan 1, 2022
-6.50 INR
Jan 1, 2023
6.75 INR
Jan 1, 2024
-11.64 INR
Jan 1, 2025
9.61 INR
The Parnax Lab FCF Yield history
YEARFCF YieldYoY
9.61 %-182.58%
-11.64 %-272.56%
6.75 %-203.75%
-6.50 %+3,914.76%
-0.16 %-94.79%
-3.11 %+70.29%
-1.82 %-134.04%
5.36 %+982.94%
0.50 %-126.72%
-1.85 %-34.63%
-2.83 %-30.09%
-4.05 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

Free Cash Flow Yield of Parnax Lab is 9.61 % in 2025.

Free Cash Flow Yield of Parnax Lab changed from -11.64 % to 9.61 %, representing a -182.58% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Parnax Lab with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Parnax Lab

All Key Metrics — Parnax Lab